Skip to main content
CMIIUNasdaqinactive

Columbus Circle Capital Corp II Unit

·New York, NY, United States·CEO: Mr. Gary Quin

CMIIU evidence brief

What we can confirm

No verified snapshot fields are available yet.

What it means

The company data is ready for cross-source review; unsupported conclusions remain unknown.

What to watch

Watch the next source-backed data update.
BioSniper AIPage evidence connected

Prepared research question

What matters most for CMIIU—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

6.7/10

BioSniper Score

Based on 2 of 6 signals

Limited data coverage

Market Cap

Cash Runway

13.1 mo

Lead Asset

Next Catalyst

Financial data as of Mar 31, 2026.

Run Columbus Circle Capital Corp II Unit through your own thesis

Use the pipeline, catalyst, financial, FDA, and market facts on this page as inputs to a protocol you control.

Your protocol can:

  • Turn available Columbus Circle Capital Corp II Unit facts into screen rules or deeper checks
  • Show cited findings, blockers, and unresolved evidence together
  • Save the logic and rerun it as the company evidence changes
Run a thesis on this company — freeRun a thesis on this company

Score breakdownBased on 2 of 6 signals · derived from public data

No clinical pipeline tracked — this score reflects financial & catalyst signals only.

Cash Runway3.6

13.1 months

Financial Health9.8

D/E 0.07

Pipeline MaturityN/A

No tracked pipeline phase

Pipeline BreadthN/A

No tracked pipeline candidates

Catalyst MomentumN/A

No upcoming catalysts tracked

Insider SignalN/A

No insider transactions in the last 180 days

Runway

Financials

Institutional Holdings

Source: SEC Form 13F · as of Mar 2026

Institutional holders

27

Total value held

$36.8M

Showing top 10 of 27 institutional holders of Columbus Circle Capital Corp II Unit. Open the full 13F history after sign-in.

Short Interest

% of float
-
Days to cover
Shares short
-
Daily short volume (Jun 15, 2026)
20.0%

Short percent of float and days-to-cover reflect reported short positioning. Daily short volume is the exchange-reported short share of a single day's trading volume and is noisier. See the most-shorted biotech ranking →

CMIIU short interest

Governance

Frequently asked questions

Who is the CEO of Columbus Circle Capital Corp II Unit?

Mr. Gary Quin is the chief executive officer of Columbus Circle Capital Corp II Unit (CMIIU).

Where is Columbus Circle Capital Corp II Unit headquartered?

Columbus Circle Capital Corp II Unit (CMIIU) is headquartered in New York, NY, United States.

925 companies232,681 SEC filings21,419 clinical trials100% citation-verification pass rate (7d)How we verify →

The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.